Literature DB >> 31371505

Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson's disease.

Joohyung Lee1,2, Paulo Pinares-Garcia3,2, Hannah Loke3, Seungmin Ham3, Eric Vilain4, Vincent R Harley1,2.   

Abstract

Parkinson's disease (PD) is a debilitating neurodegenerative disorder caused by the loss of midbrain dopamine (DA) neurons. While the cause of DA cell loss in PD is unknown, male sex is a strong risk factor. Aside from the protective actions of sex hormones in females, emerging evidence suggests that sex-chromosome genes contribute to the male bias in PD. We previously showed that the Y-chromosome gene, SRY, directly regulates adult brain function in males independent of gonadal hormone influence. SRY protein colocalizes with DA neurons in the male substantia nigra, where it regulates DA biosynthesis and voluntary movement. Here we demonstrate that nigral SRY expression is highly and persistently up-regulated in animal and human cell culture models of PD. Remarkably, lowering nigral SRY expression with antisense oligonucleotides in male rats diminished motor deficits and nigral DA cell loss in 6-hydroxydopamine (6-OHDA)-induced and rotenone-induced rat models of PD. The protective effect of the SRY antisense oligonucleotides was associated with male-specific attenuation of DNA damage, mitochondrial degradation, and neuroinflammation in the toxin-induced rat models of PD. Moreover, reducing nigral SRY expression diminished or removed the male bias in nigrostriatal degeneration, mitochondrial degradation, DNA damage, and neuroinflammation in the 6-OHDA rat model of PD, suggesting that SRY directly contributes to the sex differences in PD. These findings demonstrate that SRY directs a previously unrecognized male-specific mechanism of DA cell death and suggests that suppressing nigral Sry synthesis represents a sex-specific strategy to slow or prevent DA cell loss in PD.

Entities:  

Keywords:  brain sex differences; inflammation; neuroprotection; sex chromosome; transcription factor

Year:  2019        PMID: 31371505      PMCID: PMC6697880          DOI: 10.1073/pnas.1900406116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  The effect of estrogen replacement on early Parkinson's disease.

Authors:  R Saunders-Pullman; J Gordon-Elliott; M Parides; S Fahn; H R Saunders; S Bressman
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

Review 2.  Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?

Authors:  Rachel Saunders-Pullman
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

3.  Sex chromosome genes directly affect brain sexual differentiation.

Authors:  Laura L Carruth; Ingrid Reisert; Arthur P Arnold
Journal:  Nat Neurosci       Date:  2002-10       Impact factor: 24.884

4.  Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory.

Authors:  C Leranth; R H Roth; J D Elsworth; F Naftolin; T L Horvath; D E Redmond
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

Authors:  M D Benedetti; D M Maraganore; J H Bower; S K McDonnell; B J Peterson; J E Ahlskog; D J Schaid; W A Rocca
Journal:  Mov Disord       Date:  2001-09       Impact factor: 10.338

6.  Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

Authors:  M Baldereschi; A Di Carlo; W A Rocca; P Vanni; S Maggi; E Perissinotto; F Grigoletto; L Amaducci; D Inzitari
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

7.  Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.

Authors:  H E Murray; A V Pillai; S R McArthur; N Razvi; K P Datla; D T Dexter; G E Gillies
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

Authors:  Stephen K Van Den Eeden; Caroline M Tanner; Allan L Bernstein; Robin D Fross; Amethyst Leimpeter; Daniel A Bloch; Lorene M Nelson
Journal:  Am J Epidemiol       Date:  2003-06-01       Impact factor: 4.897

9.  Regulation of tyrosine hydroxylase gene transcription by Sry.

Authors:  Amy Milsted; Lidia Serova; Esther L Sabban; Gail Dunphy; Monte E Turner; Daniel L Ely
Journal:  Neurosci Lett       Date:  2004-10-21       Impact factor: 3.046

10.  Are men at greater risk for Parkinson's disease than women?

Authors:  G F Wooten; L J Currie; V E Bovbjerg; J K Lee; J Patrie
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

View more
  18 in total

Review 1.  Towards improved genetic diagnosis of human differences of sex development.

Authors:  Emmanuèle C Délot; Eric Vilain
Journal:  Nat Rev Genet       Date:  2021-06-03       Impact factor: 53.242

2.  Sex: a key consideration in understanding the etiology of psychiatric disorders and improving treatment

Authors:  Cara Tannenbaum; Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2019-11-01       Impact factor: 6.186

Review 3.  Mosaic loss of human Y chromosome: what, how and why.

Authors:  Xihan Guo; Xueqin Dai; Tao Zhou; Han Wang; Juan Ni; Jinglun Xue; Xu Wang
Journal:  Hum Genet       Date:  2020-02-04       Impact factor: 4.132

Review 4.  Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress.

Authors:  Nathalie Sumien; J Thomas Cunningham; Delaney L Davis; Rachel Engelland; Oluwadarasimi Fadeyibi; George E Farmer; Steve Mabry; Paapa Mensah-Kane; Oanh T P Trinh; Philip H Vann; E Nicole Wilson; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2021-11-01       Impact factor: 5.051

Review 5.  Sex Differences in Dopaminergic Vulnerability to Environmental Toxicants - Implications for Parkinson's Disease.

Authors:  Ashley Adamson; Silas A Buck; Zachary Freyberg; Briana R De Miranda
Journal:  Curr Environ Health Rep       Date:  2022-10-06

6.  Paternal Cannabis Exposure Prior to Mating, but Not Δ9-Tetrahydrocannabinol, Elicits Deficits in Dopaminergic Synaptic Activity in the Offspring.

Authors:  Theodore A Slotkin; Edward D Levin; Frederic J Seidler
Journal:  Toxicol Sci       Date:  2021-11-24       Impact factor: 4.109

7.  Sexual differences in mitochondrial and related proteins in rat cerebral microvessels: A proteomic approach.

Authors:  Sinisa Cikic; Partha K Chandra; Jarrod C Harman; Ibolya Rutkai; Prasad Vg Katakam; Jessie J Guidry; Jeffrey M Gidday; David W Busija
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-02       Impact factor: 6.200

8.  Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-β-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons.

Authors:  Sara M Zarate; Gauri Pandey; Sunanda Chilukuri; Jose A Garcia; Brittany Cude; Shannon Storey; Nihal A Salem; Eric A Bancroft; Michelle Hook; Rahul Srinivasan
Journal:  J Neurochem       Date:  2021-01-10       Impact factor: 5.372

Review 9.  Let's Talk About Sex-Biological Sex Is Underreported in Biomaterial Studies.

Authors:  Bryan D James; Paxton Guerin; Josephine B Allen
Journal:  Adv Healthc Mater       Date:  2020-10-11       Impact factor: 9.933

Review 10.  Sex differences in the response to oxidative and proteolytic stress.

Authors:  John Tower; Laura C D Pomatto; Kelvin J A Davies
Journal:  Redox Biol       Date:  2020-03-09       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.